Antistaphylococcal agents

Infectious Disease Clinics of North America
Howard S Gold, Satish K Pillai

Abstract

These are interesting times in the treatment of infections caused by Staphylococcus aureus, with shifting epidemiology of antibiotic resistance; changing prevalence of clinical syndromes (probably reflecting changes in virulence of circulating strains); and the recent availability of a variety of new agents with activity against multidrug-resistant gram-positive cocci. The abundance of riches in new drugs for the multidrug-resistant gram-positive space is timely, and these agents show great potential, but as yet have incompletely tested durability and comparative efficacy. This article reviews the advantages and disadvantages of a variety of antistaphylococcal agents by providing basic information including mechanism of action; mechanisms of resistance; clinical use (including dosing for and data supporting common indications); drug toxicities; and major drug interactions.

References

May 1, 1979·Annals of Internal Medicine·B AbramsR Greenman
Jun 1, 1992·Antimicrobial Agents and Chemotherapy·M J RybakL H Warbasse
Jun 1, 1992·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·A F WidmerW Zimmerli
Jun 1, 1991·The Journal of Infectious Diseases·H M BlumbergI K Wachsmuth
Apr 1, 1990·The Journal of Antimicrobial Chemotherapy·M J RybakP H Chandrasekar
Jun 1, 1990·Antimicrobial Agents and Chemotherapy·P M Small, H F Chambers
Feb 1, 1989·Antimicrobial Agents and Chemotherapy·S M SmithF Tecson-Tumang
Dec 1, 1988·The Journal of Antimicrobial Chemotherapy·V YeldandiJ R Lentino
May 1, 1987·The Journal of Antimicrobial Chemotherapy·W M ScheldJ P Brodeur
Sep 1, 1973·Antimicrobial Agents and Chemotherapy·M C Lobo, G L Mandell
Jul 1, 1983·Reviews of Infectious Diseases·W Wehrli
Jul 1, 1983·Reviews of Infectious Diseases·A W KarchmerW E Dismukes
Jul 1, 1983·Reviews of Infectious Diseases·C ThornsberryL K McDougal
Mar 1, 1982·Reviews of Infectious Diseases·D H Lawson, B J Paice
Jul 1, 1995·Canadian Journal of Anaesthesia = Journal Canadien D'anesthésie·O al Ahdal, D R Bevan
Mar 1, 1994·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·E J DannA E Moses
May 1, 1994·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·M L GraysonA W Karchmer
Jun 1, 1993·Antimicrobial Agents and Chemotherapy·M DrancourtD Raoult
Apr 1, 1993·The Journal of Antimicrobial Chemotherapy·C DuckworthC H Wray
Aug 7, 1997·The New England Journal of Medicine·A E Glatt
May 1, 1997·The Journal of Antimicrobial Chemotherapy·C CocitoP Vannuffel
Jul 16, 1999·BMJ : British Medical Journal·R ThurnheerR Speich
Sep 3, 1999·Mayo Clinic Proceedings·M J Kasten
Oct 26, 1999·The Annals of Pharmacotherapy·L A Fromm, D L Graham
Jan 11, 2000·The Journal of Antimicrobial Chemotherapy·J A Hoogkamp-Korstanje, J Roelofs-Willemse
Feb 15, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·E RubinsteinUNKNOWN Linezolid Nosocomial Pneumonia Study Group
May 1, 2001·The Journal of Antimicrobial Chemotherapy·A J O'NeillI Chopra

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Carbapenems (ASM)

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Carbapenems

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.

Cellulitis

Cellulitis (erysipelas) is a recurring and debilitating bacterial infection of the skin and underlying tissue. Discover the latest research on cellulitis here.

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Anaphylaxis

Anaphylaxis is a serious allergic reaction that is rapid in onset and may cause death.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

CSF & Lymphatic System

This feed focuses on Cerebral Spinal Fluid (CSF) and the lymphatic system. Discover the latest papers using imaging techniques to track CSF outflow into the lymphatic system in animal models.